National Healthcare Agreement: PI 68-Proportion of recurrent health expenditure spent on health research and development, 2012
Indicator Attributes
Identifying and definitional attributes | |
Metadata item type: | Indicator |
---|---|
Indicator type: | Progress measure |
Short name: | PI 68-Proportion of recurrent health expenditure spent on health research and development, 2012 |
METEOR identifier: | 436962 |
Registration status: | Health!, Retired 25/06/2013 |
Description: | Proportion of recurrent health expenditure spent on health research and development. |
Indicator set: | National Healthcare Agreement (2012) Health!, Superseded 25/06/2013 |
Outcome area: | Sustainability Health!, Standard 07/07/2010 |
Data quality statement: | National Healthcare Agreement: PI 68-Proportion of health expenditure spent on health research and development, 2012 QS Health!, Retired 14/01/2015 |
Collection and usage attributes | |
Computation description: | Health research and development expenditure comprises health research expenditure, undertaken at tertiary institutions, in private non-profit organisations and in government facilities that has a health socio-economic objective, excluding that funded by private business. Health socio-economic objective is defined by Division 92 in the Socio-economic classification of the 2008 ABS and Statistics New Zealand Australian and New Zealand Standard Research Classification (ABS and Statistics New Zealand 2008), ABS cat. no. 1297.0. Excludes commercially oriented research carried out or funded by private business, the costs of which are assumed to be included in the prices charged for the goods and services, e.g. medications that have been developed and/or supported by research activities. Presented as: |
---|---|
Computation: | 100 × (Numerator ÷ Denominator) |
Numerator: | Health research and experimental development recurrent expenditure |
Numerator data elements: | |
Denominator: | Total recurrent health expenditure |
Denominator data elements: | |
Disaggregation: | 2007–08 and 2008–09 (updated as necessary for revised total recurrent health expenditure estimates) and 2009–10—State and territory by source of funding. |
Disaggregation data elements: | |
Comments: | Most recent data available for 2012 CRC report: 2009–10. The AIHW estimates of research expenditure are derived from unpublished ABS data collected in the ABS Surveys of research and experimental development (ABS cat. no. 8111.0, Research and Experimental Development, Higher Education Organisations, Australia, 2006–07 and 2008–09; and ABS cat. no. 8109.0, Research and Experimental Development, Government and Private Non-Profit Organisations, Australia, 2006–07 and 2008–09). These data are available every two years. For in-between years, the AIHW makes estimates based on interpolation. |
Representational attributes | |
Representation class: | Percentage |
Data type: | Real |
Unit of measure: | Currency |
Format: | N.N |
Indicator conceptual framework | |
Framework and dimensions: | Efficiency & Sustainability Effectiveness |
Data source attributes | |
Data sources: | |
Accountability attributes | |
Reporting requirements: | National Healthcare Agreement |
Organisation responsible for providing data: | Australian Institute of Health and Welfare |
Further data development / collection required: | Specification: Long-term |
Relational attributes | |
Related metadata references: | Supersedes National Healthcare Agreement: PI 68-Proportion of health expenditure spent on health research and development, 2011 Health!, Superseded 31/10/2011 |